AIBIOS K.K.
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $7M
Investors
- 3
About AIBIOS K.K.
K.K. is engaged in the development of healthcare solutions. The company operates from its headquarters in Tokyo, Japan.K. specializes in innovative preventative healthcare methods and new pharmaceutical developments for health management, testing, and treatment of humans and animals. Their main offerings include advanced immunotherapy solutions targeting gastrointestinal, oncology, and neuroscience diseases.K. generates revenue through the development and distribution of its healthcare products, primarily utilizing a B2B model. The company forms partnerships with veterinary clinics, healthcare providers, and research institutions to integrate its advanced therapies into clinical practices. Revenue is derived from direct sales agreements with veterinary practices that purchase AIBIOS's products for treatment, as well as from research partnerships that facilitate the commercialization of new therapies.K. The company is focusing on advancing its cancer immunity research and is committed to collaborating with medical institutions and pharmaceutical companies to discover new drugs that address unmet medical needs. AIBIOS is also exploring expansion into new markets, particularly targeting increased presence in regions with rising demands for biopharmaceutical solutions.
Who invested in AIBIOS K.K.
3 investors across 1 round
See all investors in AIBIOS K.K.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 16, 2021
Amount
$7M
Investors
Questions about AIBIOS K.K.
Who invested in AIBIOS K.K.?
AIBIOS K.K. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AIBIOS K.K. raised?
AIBIOS K.K. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AIBIOS K.K. last raise money?
AIBIOS K.K.'s most recent round on record is a Series B, in Jun 2021.
What does AIBIOS K.K. do?
AIBIOS K.K. is a biotechnology company.
Where is AIBIOS K.K. headquartered?
AIBIOS K.K. is headquartered in Tokyo, Japan.
Which VCs invest in companies like AIBIOS K.K.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at AIBIOS K.K.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AIBIOS K.K.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.